Eledon Pharmaceuticals, Inc. (ELDN) shareholders
Close on Nov 17, 2026Market cap $160.90MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Bvf Inc/Il Joint filing with Bvf Partners L P/Il (9.99%), Lampert Mark N (9.99%) and 3 more | 7,868,419 | 9.99% | 13G (passive) amendment | Mar 31, 2026 |
| Matthew D. Perry Joint filing with Coastlands Capital LP (5.28%), Coastlands Capital Partners LP (5.28%) and 2 more | 4,762,691 | 5.98% | 13G (passive) | Nov 19, 2025 |
| BlackRock, Inc. | 4,380,857 | 5.80% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ELDN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Bvf Inc/Il | 6,293,282 | 7.74% | $24.80M | – | 0.63% |
| BlackRock, Inc. | 5,123,842 | 6.31% | $20.19M | +741,597 | 0.00% |
| Defilade Capital Management, L.P. | 3,525,338 | 4.34% | $13.89M | −38,789 | 1.86% |
| Vanguard Capital Management LLC | 3,417,223 | 4.21% | $13.46M | +124,089 | 0.00% |
| Goldman Sachs Group Inc | 2,510,308 | 3.09% | $9.89M | +2,140,218 | 0.00% |
| Ensign Peak Advisors, Inc | 2,101,224 | 2.59% | $8.28M | −363,695 | 0.01% |
| Geode Capital Management, LLC | 1,956,601 | 2.41% | $7.71M | +164,818 | 0.00% |
| Catalio Capital Management, LP | 1,695,071 | 2.09% | $6.68M | +55,255 | 1.26% |
| State Street Corp | 1,621,969 | 2.00% | $6.39M | +467,298 | 0.00% |
| Zimmer Partners, LP | 1,596,599 | 1.96% | $6.29M | −278,401 | 0.14% |
| Sphera Funds Management Ltd. | 1,191,187 | 1.47% | $4.69M | −580,944 | 0.61% |
| AWM Investment Company, Inc. | 1,100,000 | 1.35% | $4.33M | – | 0.38% |
| UBS Group AG | 1,048,245 | 1.29% | $4.13M | +500,798 | 0.00% |
| Kingdon Capital Management, L.L.C. | 1,039,275 | 1.28% | $4.09M | – | 0.42% |
| Millennium Management LLC | 979,712 | 1.21% | $3.86M | New | 0.00% |
| Bank Of America Corp /De/ | 883,097 | 1.09% | $3.48M | +13,553 | 0.00% |
| ADAR1 Capital Management, LLC | 647,812 | 0.80% | $2.55M | −326,609 | 0.12% |
| 22NW, LP | 636,364 | 0.78% | $2.51M | – | 2.40% |
| Northern Trust Corp | 616,399 | 0.76% | $2.43M | +72,557 | 0.00% |
| Aqr Capital Management LLC | 581,028 | 0.72% | $2.29M | +408,611 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 161 | 47M | 57.8% | 51 / 62 | 22 / 9 | 10M | 5M |
| Q1 2026 | 121 | 43M | 52.4% | 42 / 35 | 20 / 15 | 8M | 6M |
| Q4 2025 | 95 | 44M | 54.3% | 32 / 32 | 17 / 19 | 18M | 11M |
| Q3 2025 | 83 | 36M | 44.9% | 21 / 23 | 22 / 21 | 7M | 11M |
| Q2 2025 | 85 | 41M | 50.3% | 28 / 21 | 15 / 26 | 6M | 4M |
| Q1 2025 | 83 | 38M | 47.3% | 18 / 17 | 21 / 10 | 4M | 5M |
| Q4 2024 | 75 | 38M | 47.4% | 45 / 19 | 2 / 3 | 23M | 3M |
| Q3 2024 | 33 | 18M | 22.7% | 3 / 9 | 7 / 1 | 1M | 1M |
| Q2 2024 | 32 | 19M | 23.2% | 7 / 14 | 2 / 4 | 9M | 0M |
| Q1 2024 | 29 | 10M | 11.8% | 3 / 9 | 8 / 3 | 1M | 0M |
| Q4 2023 | 29 | 9M | 11.3% | 5 / 8 | 7 / 3 | 1M | 0M |
| Q3 2023 | 28 | 9M | 11.0% | 3 / 8 | 9 / 8 | 0M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
97 funds held ELDN in Q2 2026, 67% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ELDN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2,483,162 | 3.06% | $9.78M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 2,038,160 | 2.51% | $8.03M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 854,634 | 1.05% | $3.37M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 839,205 | 1.03% | $2.84M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 723,407 | 0.89% | $2.85M | 0.02% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 389,371 | 0.48% | $1.48M | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 383,983 | 0.47% | $1.46M | 0.01% | May 31, 2026 |
| Goldman Sachs Small Cap Equity Insights Fund | 311,993 | 0.38% | $1.05M | 0.10% | Jul 31, 2026 |
| Goldman Sachs Small Cap Value Insights Fund | 286,012 | 0.35% | $966.72K | 0.07% | Jul 31, 2026 |
| iShares Micro-Cap ETF | 255,233 | 0.31% | $1.01M | 0.07% | Jun 30, 2026 |
| Dimensional U.S. Small Cap ETF | 196,897 | 0.24% | $665.51K | 0.00% | Jul 31, 2026 |
| Schwab Small-Cap Index Fund | 187,417 | 0.23% | $633.47K | 0.01% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 141,649 | 0.17% | $539.68K | 0.00% | May 31, 2026 |
| Master Small Cap Index Series | 134,953 | 0.17% | $531.71K | 0.01% | Jun 30, 2026 |
| Goldman Sachs Small Cap Growth Insights Fund | 129,548 | 0.16% | $437.87K | 0.13% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David-Alexandre C. Gros | Chief Executive Officer, Director | 363,454 | 0.45% | Aug 4, 2026 |
| Steven Perrin | President, Director | 153,353 | 0.19% | Aug 4, 2026 |
| Paul Sean Little | Chief Financial Officer | 10,000 | 0.01% | Jan 13, 2025 |
| Bryan E. Smith | General Counsel, Corporate Sec | – | – | Jan 13, 2025 |
| Jan Hillson | Director | 3,430 | 0.00% | Jan 16, 2026 |
| James A. Robinson Jr. | Director | 3,430 | 0.00% | Jan 16, 2026 |
| Allan Kirk | Director | 3,430 | 0.00% | Jan 16, 2026 |
| John S. McBride | Director | 3,430 | 0.00% | Jan 16, 2026 |
| Keith Katkin | Director | 8,575 | 0.01% | Jan 16, 2026 |
| June Lee | Director | 3,430 | 0.00% | Jan 16, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| David-Alexandre C. Gros Chief Executive Officer, Director | Jul 31, 2026 | Award | +354,454 | – | – | 363,454 |
| David-Alexandre C. Gros Chief Executive Officer, Director | Jul 31, 2026 | Tax withholding | −194,791 | $3.38 | $658.39K | 168,663 |
| Steven Perrin President, Director | Jul 31, 2026 | Award | +152,353 | – | – | 153,353 |
| Steven Perrin President, Director | Jul 31, 2026 | Tax withholding | −72,138 | $3.38 | $243.83K | 81,215 |
| John S. McBride Director | Jan 10, 2026 | Option exercise | +3,430 | – | – | 3,430 |
| Jan Hillson Director | Jan 10, 2026 | Option exercise | +3,430 | – | – | 3,430 |
| James A. Robinson Jr. Director | Jan 10, 2026 | Option exercise | +3,430 | – | – | 3,430 |
| June Lee Director | Jan 10, 2026 | Option exercise | +3,430 | – | – | 3,430 |
| Allan Kirk Director | Jan 10, 2026 | Option exercise | +3,430 | – | – | 3,430 |
| Keith Katkin Director | Jan 10, 2026 | Option exercise | +8,575 | – | – | 8,575 |
| Inc/Il Bvf 10% owner | May 9, 2024 | Buy | +75,431 | – | – | 220,460 |
| Inc/Il Bvf 10% owner | May 9, 2024 | Buy | +821,121 | – | – | 2,633,679 |
| Inc/Il Bvf 10% owner | May 9, 2024 | Buy | +1,031,385 | – | – | 3,361,803 |
| Value Trading Fund OS LP Biotechnology – | May 5, 2023 | Buy | +1,055,445 | – | – | 2,330,418 |
| Value Trading Fund OS LP Biotechnology – | May 5, 2023 | Buy | +86,341 | – | – | 145,029 |
| Value Trading Fund OS LP Biotechnology – | May 5, 2023 | Buy | +837,146 | – | – | 1,812,558 |
| Steven Perrin President, Director | Nov 23, 2022 | Buy | +1,000 | $2.60 | $2.60K | 1,000 |
| David-Alexandre C. Gros Chief Executive Officer, Director | Dec 20, 2021 | Buy | +2,000 | $4.48 | $8.96K | 9,000 |
| David-Alexandre C. Gros Chief Executive Officer, Director | Aug 17, 2021 | Buy | +4,000 | $6.21 | $24.84K | 7,000 |
| Paul Sean Little CHIEF FINANCIAL OFFICER | Jun 11, 2021 | Buy | +10,000 | $8.87 | $88.70K | 10,000 |
| David-Alexandre C. Gros Chief Executive Officer, Director | Jun 9, 2021 | Buy | +3,000 | $8.01 | $24.03K | 3,000 |
| Mark N. Lampert – | Dec 22, 2020 | Conversion | +11,278 | – | – | 89,214 |
| Mark N. Lampert – | Dec 22, 2020 | Conversion | +15,166 | – | – | 117,565 |
| Mark N. Lampert – | Dec 22, 2020 | Conversion | +654,215 | – | – | 771,780 |
| Mark N. Lampert – | Dec 22, 2020 | Conversion | +509,410 | – | – | 598,624 |
| Mark N. Lampert – | Dec 22, 2020 | Conversion | +97,615 | – | – | 113,152 |
| Mark N. Lampert – | Dec 22, 2020 | Conversion | +1,944 | – | – | 15,537 |
| Israel GP Ltd. OrbiMed 10% owner | Dec 2, 2020 | Sale | −103,200 | $21.60 | $2.23M | 73,650 |
| Global Management LP Logos 10% owner | Oct 30, 2020 | Sale | −12,942 | $26.64 | $344.77K | 187,058 |
| Global Management LP Logos 10% owner | Oct 30, 2020 | Buy | +15,000 | $26.17 | $392.55K | 214,973 |
| Global Management LP Logos 10% owner | Oct 30, 2020 | Sale | −27 | $27.02 | $730 | 199,973 |
| Global Management LP Logos 10% owner | Oct 30, 2020 | Buy | +12,942 | $25.88 | $334.94K | 200,000 |
| Global Management LP Logos 10% owner | Oct 30, 2020 | Buy | +9,098 | $25.55 | $232.45K | 224,071 |
| Global Management LP Logos 10% owner | Oct 30, 2020 | Buy | +15,000 | $26.48 | $397.20K | 200,000 |
| Global Management LP Logos 10% owner | Oct 30, 2020 | Buy | +4,000 | $25.97 | $103.88K | 185,000 |
| Global Management LP Logos 10% owner | Oct 30, 2020 | Buy | +31,000 | $24.53 | $760.43K | 181,000 |
| Global Management LP Logos 10% owner | Oct 30, 2020 | Buy | +5,000 | $24.03 | $120.15K | 150,000 |
| Jon Kuwahara See Remarks | May 21, 2019 | Sale | −1,058 | $1.91 | $2.02K | 5,974 |
| Gregory J. Flesher Chief Executive Officer, Director | May 21, 2019 | Sale | −2,937 | $1.91 | $5.61K | 156,918 |
| Catherine C. Turkel President | May 21, 2019 | Sale | −1,914 | $1.91 | $3.66K | 88,662 |
| Jon Kuwahara See Remarks | May 20, 2019 | Sale | −4,218 | $1.96 | $8.27K | 7,032 |
| Gregory J. Flesher Chief Executive Officer, Director | May 20, 2019 | Sale | −11,701 | $1.96 | $22.93K | 159,855 |
| Catherine C. Turkel President | May 20, 2019 | Sale | −7,623 | $1.96 | $14.94K | 90,576 |
| Israel BioFund GP Limited Partnership OrbiMed Director, 10% owner | May 2, 2019 | Buy | +646,204 | $3.10 | $2.00M | 3,183,314 |
| Erez Chimovits Director | May 2, 2019 | Buy | +646,204 | $3.10 | $2.00M | 3,183,314 |
| Paul Yook 10% owner | Apr 30, 2019 | Sale | −200 | $2.70 | $540 | 1,065,867 |
| Catherine C. Turkel President | Mar 14, 2019 | Award | +20,000 | – | – | 98,199 |
| Gregory J. Flesher Chief Executive Officer, Director | Mar 14, 2019 | Award | +25,000 | – | – | 171,556 |
| Catherine C. Turkel President | Sep 12, 2018 | Buy | +16,632 | $5.02 | $83.49K | 78,199 |
| Catherine C. Turkel President | Sep 11, 2018 | Buy | +17,048 | $4.56 | $77.74K | 61,567 |
| Catherine C. Turkel President | Sep 5, 2018 | Buy | +805 | $3.97 | $3.20K | 805 |
| Jon Kuwahara See Remarks | Mar 13, 2018 | Award | +11,250 | – | – | 11,250 |
| Catherine C. Turkel President | Mar 13, 2018 | Award | +20,000 | – | – | 44,519 |
| Gregory J. Flesher Chief Executive Officer, Director | Mar 13, 2018 | Award | +30,700 | – | – | 146,556 |
| Gregory J. Flesher Chief Executive Officer, Director | May 10, 2017 | Buy | +58,959 | $9.99 | $589.00K | 115,856 |
| Catherine C. Turkel Chief Development Officer | May 10, 2017 | Buy | +11,111 | $9.99 | $111.00K | 24,519 |
| Christine Ocampo See Remarks | May 10, 2017 | Buy | +10,010 | $9.99 | $100.00K | 21,590 |
| Israel BioFund GP Limited Partnership OrbiMed Director, 10% owner | May 9, 2017 | Award | +2,537,110 | – | – | 2,537,110 |
| Stephen Buckley Jr. Director | Mar 15, 2016 | Buy | +8,000 | $5.74 | $45.92K | 11,000 |
| Jodie Pope Morrison President and CEO, Director | Jan 8, 2016 | Option exercise | +20,000 | $1.37 | $27.40K | 57,566 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Eledon Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 66,263 shares on Aug 26, 2026 over the last 90 days.
See a number that looks wrong?